CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 129 enrolled
Drug / intervention
Oxycodone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05327777
NCT05327777Phase 4Completed
CompareCT.gov

Toward Zero Prescribed Opioids for Outpatient General Surgery Procedures: a Prospective Cohort Trial

Thomas Jefferson University·interventional·Posted Apr 14, 2022·Updated Jun 5, 2023

In Brief

A Phase 4 clinical trial evaluating Oxycodone and Zero Opioid Protocol for Opioid Misuse and Addiction and Pain. Completed, enrolled 129 participants across 1 site.

Detailed Summary

Investigators have created an opioid reduction "package" which includes patient education, non-narcotic pain control instructions, and limited (or no) opioid pain prescriptions provided at discharge in an attempt to reduce the number of opioid consumption after outpatient general surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid Misuse and Addiction, Pain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedApr 14, 2022
Enrollment StartNov 1, 2019
Primary CompletionJul 30, 2021
Study CompletionMar 15, 2023
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 4.2 years ago

Interventions

Oxycodonedrug

Investigators provided set opioid prescriptions for 10 pills each patient.

Zero Opioid Protocolbehavioral

Investigators provided no opioid prescriptions at discharge and instead provided information on non-narcotic pain control.